Roquefort Therapeutics (ROQ)

Sector:

Alternative Investment Instruments

 1.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 6.25
  • 52 Week Low: 1.23
  • Currency: UK Pounds
  • Shares Issued: 157.44m
  • Volume: 151,915
  • Market Cap: £2.05m
  • Beta: 0.00

ROQ Overview

We established Roquefort Therapeutics plc to acquire businesses focused on early-stage opportunities in the medical biotechnology sector with the aim of generating optimal returns for both the target businesses and our shareholders. The investment strategy of the Company is to provide Shareholders with an attractive total return achieved primarily through capital appreciation. The Directors believe that there are numerous investment opportunities within both private and public businesses in the medical biotech sector in the United Kingdom, Continental Europe and Australia.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 0.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ROQ Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (0.92) (3.71)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.63) (1.56)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.20 (1.93) (1.35)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (1.21) (0.75)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ROQ Company Announcements

Director/PDMR Shareholding 30-Jun-2025 07:00 RNS
Lyramid SPA Extension 27-Jun-2025 07:00 RNS
Results of AGM 26-Jun-2025 13:00 RNS

ROQ ShareCast News

No recent information was found.

Latest ROQ Director Deals

Traded Action Notifier PriceAmountValue
27-Jun-25 Buy Simon Sinclair 1.37p 72,507 £993.35

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ROQ Market Data

Currency UK Pounds
Share Price 1.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 6.25
52 Week Low 1.23
Volume 151,915
Shares Issued 157.44m
Market Cap £2.05m
Beta 0.00

ROQ Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.72% above the market average46.72% above the market average46.72% above the market average46.72% above the market average46.72% above the market average
70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average
Price Trend
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
96.36% below the sector average96.36% below the sector average96.36% below the sector average96.36% below the sector average96.36% below the sector average
Income Not Available
Growth Not Available

ROQ Dividends

No dividends found

Trades for 04-Jul-2025

Time Volume / Share Price
16:21 50,412 @ 1.23p
15:27 32,991 @ 1.44p
10:24 40,164 @ 1.23p
09:41 10,902 @ 1.44p
08:00 17,446 @ 1.44p

Top of Page